HKD 1.64
(1.86%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 226.72 Million USD | 5.58% |
2022 | 214.74 Million USD | 40.58% |
2021 | 152.75 Million USD | 62.78% |
2020 | 93.84 Million USD | 87.72% |
2019 | 49.99 Million USD | 47.77% |
2018 | 33.83 Million USD | 25.43% |
2017 | 26.97 Million USD | 13.05% |
2016 | 23.85 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 231.62 Million USD | 0.0% |
2023 Q2 | 198.08 Million USD | 0.0% |
2023 Q4 | 226.72 Million USD | 0.0% |
2023 FY | 226.72 Million USD | 5.58% |
2022 Q4 | 214.74 Million USD | 0.0% |
2022 FY | 214.74 Million USD | 40.58% |
2022 Q2 | 164.92 Million USD | 0.0% |
2021 Q4 | 152.75 Million USD | 0.0% |
2021 FY | 152.75 Million USD | 62.78% |
2021 Q2 | 97.45 Million USD | 0.0% |
2020 Q2 | 69.14 Million USD | 0.0% |
2020 Q4 | 93.84 Million USD | 0.0% |
2020 FY | 93.84 Million USD | 87.72% |
2019 FY | 49.99 Million USD | 47.77% |
2019 Q2 | 43.17 Million USD | 0.0% |
2019 Q4 | 49.99 Million USD | 0.0% |
2018 FY | 33.83 Million USD | 25.43% |
2018 Q4 | 33.83 Million USD | 0.0% |
2017 FY | 26.97 Million USD | 13.05% |
2016 FY | 23.85 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Uni-Bio Science Group Limited | 152.81 Million HKD | -48.361% |
CK Life Sciences Int'l., (Holdings) Inc. | 7.05 Billion HKD | 96.788% |